Tentative pending approval from Dr Braunwald SECTION I: EPIDEMIOLOGY 1. General Population and Global Cardiovascular Risk Prediction 2. Hypertension in Latin/Hispanic Population 3. Hypertension in East Asians and Native Hawaiians 4. Hypertension in South Asians 5. Hypertension in Women - NEW SECTION II: PATHOPHYSIOLOGY 6. Pathogenesis of Hypertension 7. Genetics of Hypertension 8.
Inflammation and Immunity in Hypertension SECTION III: DIAGNOSIS AND EVALUATION 9. Environmental Factors Affecting Blood Pressure Development 10. Office Blood Pressure Measurement 11. Home Monitoring of Blood Pressure 12. Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management 13. White Coat and Masked Hypertension 14. Secondary Hypertension: Renovascular Hypertension 15. Secondary Hypertension: Primary Hyperaldosteronism and Mineralocorticoid Excess States 16.
Secondary Hypertension: Pheochromocytoma 17. Secondary Hypertension: Sleep Disturbances including Sleep Apnea 18. Hypertension in Children: Diagnosis and Treatment SECTION IV: RISK STRATIFICATION 19. Natural History of Untreated Hypertension 20. Isolated Systolic Hypertension 21. Assessment of Target Organ Damage SECTION V: ANTIHYPERTENSIVE THERAPY 22. Diet and Blood Pressure 23. Diuretic Therapy 24.
Peripheral Adrenergic Blockers 25. Renin Angiotensin Aldosterone System Blockers 26. Calcium Channel Blockers 27. Central Sympathetic Agents and Direct Vasodilators 28. Mineralocorticoid Receptor Antagonists - NEW 29. Use of Combination Therapies 30. Devices Therapies 31. Alternative/Complementary Medicine SECTION VI: HYPERTENSION MANAGEMENT 32.
Approach to Uncomplicated Primary Hypertension 33. Ischemic Heart Disease 34. Heart Failure 35. Kidney Disease including Dialysis 36. Transplant Hypertension 37. Obesity 38. Cerebrovascular Disease 39. Diabetes Mellitus 40.
Dyslipidemia SECTION VII: SPECIAL POPULATIONS AND SPECIAL SITUATIONS 41. Hypertension in Pregnancy 42. Hypertension in Older People 43. Hypertension in African Americans 44. Baroreceptor Dysfunction/Orthostatic Hypotension 45. Resistant Hypertension 46. Hypertension and the Perioperative Period 47. Aorta and Peripheral Arterial Disease in Hypertension 48.
Hypertensive Emergencies 49. Exercise and Hypertension - NEW SECTION VIII: OUTCOME TRIALS 50. Meta-Analyses of Hypertension Trials: The Blood Pressure Lowering Treatment Trialists' Collaboration SECTION IX: HYPERTENSION TREATMENT IN THE FUTURE 51. Team-Based Care for Hypertension Management 52. Understanding and Improving Medication Adherence 53. Telemedicine and Digital Health for Hypertension Management - NEW.